These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 22900074)
1. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells. Zhang P; Liu SS; Ngan HY PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074 [TBL] [Abstract][Full Text] [Related]
2. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells. Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194 [TBL] [Abstract][Full Text] [Related]
4. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma. Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817 [TBL] [Abstract][Full Text] [Related]
5. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia. Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680 [TBL] [Abstract][Full Text] [Related]
6. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Jones EV; Dickman MJ; Whitmarsh AJ Biochem J; 2007 Aug; 405(3):617-23. PubMed ID: 17521288 [TBL] [Abstract][Full Text] [Related]
7. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125 [TBL] [Abstract][Full Text] [Related]
8. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells. Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870 [TBL] [Abstract][Full Text] [Related]
9. Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells. Helbig L; Damrot J; Hülsenbeck J; Köberle B; Brozovic A; Osmak M; Fiket Z; Kaina B; Fritz G J Biol Chem; 2011 Apr; 286(15):12991-3001. PubMed ID: 21324906 [TBL] [Abstract][Full Text] [Related]
10. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73. Tiwary R; Yu W; Sanders BG; Kline K Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929 [TBL] [Abstract][Full Text] [Related]
11. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851 [TBL] [Abstract][Full Text] [Related]
12. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. Leong CO; Vidnovic N; DeYoung MP; Sgroi D; Ellisen LW J Clin Invest; 2007 May; 117(5):1370-80. PubMed ID: 17446929 [TBL] [Abstract][Full Text] [Related]
13. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells. Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200 [TBL] [Abstract][Full Text] [Related]
14. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882 [TBL] [Abstract][Full Text] [Related]
15. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016 [TBL] [Abstract][Full Text] [Related]
16. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells. Hu X; Wu N; Xia P; Yu S; Sun F; Chen J Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403 [TBL] [Abstract][Full Text] [Related]
17. N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy. Ruhul Amin AR; Thakur VS; Gupta K; Agarwal MK; Wald DN; Shin DM; Agarwal ML Oncogene; 2013 Feb; 32(7):920-9. PubMed ID: 22430213 [TBL] [Abstract][Full Text] [Related]
18. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. John K; Alla V; Meier C; Pützer BM Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals. Song H; Wei M; Liu W; Shen S; Li J; Wang L Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251 [TBL] [Abstract][Full Text] [Related]
20. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth. Subramanian D; Bunjobpol W; Sabapathy K J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]